Darya Habibi, University of British Columbia

Research

Acute Lymphoblastic Leukemia Amino Acid Deprivation Cancer Therapy Cell Death Immune Cells Immunosuppression Non-Rejectable Allografts Skin Cells

Latest papers

Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia.
Investigational new drugs · 2012 · first author
High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.
Journal of cellular physiology · 2010 · first author
Highly efficient stable expression of indoleamine 2,3 dioxygenase gene in primary fibroblasts.
Biological procedures online · 2010

All 3 publications

Latest funding

Science to Business (2015), Sauder School of Business, University of British Columbia, MBA Program
CIHR · 2015 · Nominated PI
$30,000

All 1 grants and awards

3 publications.

01

Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia.

Habibi D, Ogloff N, Jalili RB, Yost A, Weng AP, Ghahary A, Ong CJ

Investigational new drugs2012First author

DOI: 10.1007/s10637-011-9700-y PMID: 21678129

02

High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.

Habibi D, Jalili RB, Forouzandeh F, Ong CJ, Ghahary A

Journal of cellular physiology2010First author

DOI: 10.1002/jcp.22220 PMID: 20648630

03

Highly efficient stable expression of indoleamine 2,3 dioxygenase gene in primary fibroblasts.

Rezakhanlou AM, Habibi D, Lai A, Jalili RB, Ong CJ, Ghahary A

Biological procedures online2010

DOI: 10.1007/s12575-010-9028-6 PMID: 21406070

Science to Business (2015), Sauder School of Business, University of British Columbia, MBA Program

Nominated PICIHR2015Science to Business Program

Principal investigators: Habibi, Darya

Keywords: Acute Lymphoblastic Leukemia; Amino Acid Deprivation; Cancer Therapy; Cell Death; Immune Cells; Immunosuppression; Non-Rejectable Allografts; Skin Cells; Small Molecule Drugs; Transplantation

$30,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Aziz Ghahary

Department of Surgery

3 shared papers, latest 2012

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Acute Lymphoblastic Leukemia Dear Professor Habibi, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia." (2012), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]